Jeff Boyd

Targeted therapies in endometrial cancer (EC) using kinase inhibitors rarely result in complete tumor remission and are frequently challenged by the appearance of refractory cell clones, eventually resulting in disease relapse. Dissecting a…

The molecular etiology of uterine leiomyosarcoma (ULMS) is poorly understood, which accounts for the wide disparity in outcomes among women with this disease. We examined and compared the molecular profiles of ULMS and normal myometrium (NL…

Two new mouse models have been devised that shed light on the genesis of endometriosis and endometrioid ovarian cancer, suggest drugs for the treatment of endometrioid ovarian cancer, and provide a means of testing them.